Thus, the regulation of insulin signaling and CREB/BDNF pathways in the hippocampus via SCFAs, particularly butyrate, was proposed as the mechanism by which the combination of hesperetin and metformin improved cognitive impairment in DM rats through the gut–brain–microbiota axis (Figure 9). Here, CREB1 is linked to diabetes mellitus.